Howard Bancorp, Inc. (HBMD): Price and Financial Metrics
GET POWR RATINGS... FREE!
HBMD POWR Grades
- HBMD scores best on the Momentum dimension, with a Momentum rank ahead of 91.82% of US stocks.
- The strongest trend for HBMD is in Sentiment, which has been heading down over the past 160 days.
- HBMD ranks lowest in Value; there it ranks in the 13th percentile.
HBMD Stock Summary
- The ratio of debt to operating expenses for Howard Bancorp Inc is higher than it is for about 80.72% of US stocks.
- HBMD's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of 88.48% of US stocks.
- In terms of twelve month growth in earnings before interest and taxes, Howard Bancorp Inc is reporting a growth rate of -395%; that's higher than just 4.99% of US stocks.
- If you're looking for stocks that are quantitatively similar to Howard Bancorp Inc, a group of peers worth examining would be CBFV, SBT, PNBK, ATNI, and KFFB.
- Visit HBMD's SEC page to see the company's official filings. To visit the company's web site, go to www.howardbank.com.
HBMD Valuation Summary
- HBMD's EV/EBIT ratio is 17.9; this is 108.14% higher than that of the median Financial Services stock.
- Over the past 113 months, HBMD's price/earnings ratio has gone down 1.7.
- HBMD's EV/EBIT ratio has moved up 9.2 over the prior 113 months.
Below are key valuation metrics over time for HBMD.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
HBMD | 2019-10-28 | 3.9 | 1.1 | 30.7 | 32.2 |
HBMD | 2015-10-14 | 1.8 | 1.0 | 8.2 | 7.7 |
HBMD | 2015-09-15 | 1.8 | 1.0 | 8.2 | 7.7 |
HBMD | 2015-04-30 | 1.4 | 1.0 | 5.6 | 5.9 |
HBMD | 2013-03-26 | 2.2 | 0.6 | 30.1 | 17.7 |
HBMD | 2012-07-13 | 1.4 | 0.5 | 19.0 | 4.1 |
HBMD Growth Metrics
- The 5 year net income to common stockholders growth rate now stands at 1127.36%.
- Its 4 year revenue growth rate is now at 95.51%.
- The 2 year net income to common stockholders growth rate now stands at 39046.34%.

The table below shows HBMD's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2021-09-30 | 85.353 | 35.975 | 24.489 |
2021-06-30 | 81.983 | 32.812 | 22.733 |
2021-03-31 | 79.427 | 39.863 | -14.132 |
2020-12-31 | 76.116 | 60.667 | -16.991 |
2020-09-30 | 78.127 | 76.916 | -15.562 |
2020-06-30 | 81.106 | 69.253 | -15.529 |
HBMD's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- HBMD has a Quality Grade of C, ranking ahead of 30.83% of graded US stocks.
- HBMD's asset turnover comes in at 0.032 -- ranking 339th of 430 Banking stocks.
- CURO, HOPE, and FCNCA are the stocks whose asset turnover ratios are most correlated with HBMD.
The table below shows HBMD's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-06-30 | 0.032 | 1 | 0.011 |
2021-03-31 | 0.031 | 1 | -0.003 |
2020-12-31 | 0.030 | 1 | -0.005 |
2020-09-30 | 0.032 | 1 | -0.004 |
2020-06-30 | 0.034 | 1 | -0.004 |
2020-03-31 | 0.035 | 1 | 0.008 |
HBMD Price Target
For more insight on analysts targets of HBMD, see our HBMD price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $23.50 | Average Broker Recommendation | 1.75 (Moderate Buy) |
HBMD Stock Price Chart Interactive Chart >
HBMD Price/Volume Stats
Current price | $23.30 | 52-week high | $25.36 |
Prev. close | $23.79 | 52-week low | $11.74 |
Day low | $23.23 | Volume | 1,796,600 |
Day high | $23.80 | Avg. volume | 178,186 |
50-day MA | $22.29 | Dividend yield | N/A |
200-day MA | $19.46 | Market Cap | 438.34M |
Howard Bancorp, Inc. (HBMD) Company Bio
Howard Bancorp, Inc. operates as the bank holding company for Howard Bank that provides commercial banking, mortgage banking, and consumer finance products and services to businesses, business owners, professionals, and other consumers in Maryland and Pennsylvania. The company was founded in 2004 and is based in Ellicott City, Maryland.
Latest HBMD News From Around the Web
Below are the latest news stories about Howard Bancorp Inc that investors may wish to consider to help them evaluate HBMD as an investment opportunity.
Why You Shouldn't Bet Against Howard Bancorp (HBMD) StockHoward Bancorp (HBMD) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well. |
F.N.B.'s bank buy in Baltimore approved by regulatorsF.N.B. Corp. has cleared the main hurdles to its pending acquisition in Maryland. On Tuesday, F.N.B. (NYSE:FNB) said it has received all regulatory clearances for its proposed merger with Baltimore-based Howard Bancorp Inc. Pittsburgh-based F.N.B. announced the $418 million all-stock transaction on July 13, marking its first bank buy in more than four years. The Board of Governors of the Federal Reserve System, the Office of the Comptroller of the Currency and the Maryland Office of the Commissioner of Financial Regulation have provided final clearance for the F.N.B.-Howard (NASDAQ:HBMD) merger as well as the merger of Howard's bank subsidiary, Howard Bank, into F.N.B.’s retail arm, First National Bank of Pennsylvania. |
F.N.B. Corporation Receives Final Regulatory Approval for Howard Bancorp, Inc. MergerF.N.B. Corporation (NYSE: FNB) announced it has received all regulatory clearances for its proposed merger with Howard Bancorp, Inc. (Howard) (NASDAQ: HBMD). |
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ADTN, HBMD, VNE, IKNX; Shareholders are Encouraged to Contact the FirmHalper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: |
Lifshitz Law Firm, P.C. Announces Investigation of ADMS, ACBI, FLXN, and HBMDNEW YORK, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (NasdaqGM: ADMS) Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of ADMS to Supernus Pharmaceuticals, Inc. for $8.10 in cash per share of ADMS owned. If you are an investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at |
HBMD Price Returns
1-mo | N/A |
3-mo | N/A |
6-mo | 7.03% |
1-year | 37.06% |
3-year | 60.36% |
5-year | 24.27% |
YTD | 6.93% |
2021 | 84.50% |
2020 | -30.04% |
2019 | 18.04% |
2018 | -35.00% |
2017 | 45.70% |
Continue Researching HBMD
Here are a few links from around the web to help you further your research on Howard Bancorp Inc's stock as an investment opportunity:Howard Bancorp Inc (HBMD) Stock Price | Nasdaq
Howard Bancorp Inc (HBMD) Stock Quote, History and News - Yahoo Finance
Howard Bancorp Inc (HBMD) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...